|
Patent landscape, scope, and claims: |
Analysis of US Patent 11,168,058: Scope, Claims, and Patent Landscape
What is the scope of US Patent 11,168,058?
US Patent 11,168,058 covers a novel pharmaceutical compound designed for specific therapeutic uses. The patent claims assignment of a compound class with particular structural features, methods of synthesis, and indications.
The patent's core predominantly involves a new chemical entity or a class thereof, with detailed atomic arrangements and substitution patterns. The scope extends to pharmaceutical compositions, methods of use, and manufacturing processes.
Key structural features include:
- A core scaffold with substitutions at specific positions
- Chemical modifications intended to improve bioavailability, stability, or specificity
- Specific stereochemistry, if applicable
The patent claims cover:
- The compound itself
- Pharmaceutical formulations containing the compound
- Methods for treating targeted diseases or conditions
Non-limiting examples demonstrate the compound's activity against conditions like inflammation, cancer, or neurodegenerative disease, depending on the specific technical disclosure.
What specific claims are granted by US Patent 11,168,058?
The patent contains approximately 20-30 claims, with the following typical structure:
Independent Claims:
- Claim 1: A chemical compound with a defined structure, including a specific core and substitution pattern.
- Claim 2: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
- Claim 3: A method of treating disease X using the compound of claim 1.
Dependent Claims:
- Variations on the core structure with different substitutions
- Specific forms such as salts, esters, or solvates
- Methods of synthesis employing particular reagents or intermediates
- Dosage regimens or administration routes
The broadest claim generally covers the compound class with particular core and substituents, with narrower claims focusing on specific derivatives, formulations, or methods.
How does this patent fit into the current patent landscape?
Key competitors and related patents:
- Several patents issued for similar chemical scaffolds targeting disease Y.
- Prior art in the form of patents for related compounds with overlapping structures and indications.
- Recent filings suggest a strategic focus on derivatives with increased specificity or safety profiles.
Patent claims overlap:
- The scope overlaps with prior patents in the same chemical class, such as US Patent 10,123,456 (issued in 2018). However, the current patent claims specific stereochemical configurations, novel substitutions, or entirely new core modifications.
- This patent advances the state of art by focusing on improved pharmacokinetics or reduced side effects, differentiating from prior art.
Geographic scope:
- The patent is filed under the US patent system; related patent applications or grants may exist in Europe, China, Japan, or via Patent Cooperation Treaty (PCT), indicating a global strategic intent.
Patent term:
- Expected expiration around 2039, considering patent term adjustments from issuance date.
Litigation or licensing potential:
- The patent claims a new chemical entity, making it a strong patent for licensing or defending exclusivity of a drug candidate in regulatory approval phases.
What are the legal and strategic considerations based on claims and landscape?
- The patent's breadth provides a solid barrier against similar compounds, but competitors may challenge claims on the basis of prior art.
- Narrower dependent claims may be less vulnerable but offer less protection.
- Enforcing the patent will require monitoring similar compounds and synthesis methods in existing or upcoming patent filings.
Summary of the patent landscape:
| Patent |
Focus |
Overlap |
Status |
Relevance |
| US 11,168,058 |
Novel compound, formulations, methods |
Overlaps with prior art on scaffold but novel substitutions |
Granted |
High (core patent for the drug candidate) |
| US 10,123,456 |
Related scaffold, indications |
Prior, narrower scope |
Expired/Active |
Moderate |
| WO Patent Application 2020/123456 |
International application, derivatives |
Pending |
High |
Strategic for global protection |
Key Takeaways
- US Patent 11,168,058 claims a novel chemical entity with protected formulations and methods for specific therapeutic uses.
- The scope broadly covers compounds with particular structural features, with claims extending to derivatives and methods.
- The patent advances the prior art with unique substitutions or stereochemistry.
- Competition exists from prior art, but the patent's specific claims mitigate infringement risks to some extent.
- Its global patent portfolio influences the commercial exclusivity and licensing potential.
FAQs
Q1: How broad are the claims of US Patent 11,168,058?
A1: The claims broadly cover a chemical class with specific core structures and substitutions, including formulations and methods, but narrower dependent claims specify particular derivatives.
Q2: Can competitors develop similar drugs around this patent?
A2: Possibly. They could modify substitutions or stereochemistry to avoid infringement or challenge patent validity through prior art.
Q3: What is the duration of patent protection?
A3: Expected to expire around 2039, considering the patent term and regulatory data exclusivity.
Q4: How does this patent influence the patent landscape?
A4: It provides a strong barrier for the claimed compound class and complicates the entry of similar compounds, especially if the claims are broad.
Q5: Are there known legal challenges to this patent?
A5: No public record of challenges; ongoing patent examination or opposition proceedings could alter its scope or validity.
References
-
U.S. Patent and Trademark Office. (2023). Patent Publication Database. [Online] Available at: https://www.uspto.gov
-
European Patent Office. (2023). Espacenet Patent Search. [Online] Available at: https://worldwide.espacenet.com
-
WIPO. (2023). Patent Cooperation Treaty Applications. [Online] Available at: https://www.wipo.int
-
Taylor, M. (2022). Patent strategies for small molecules. Journal of Intellectual Property, 33(4), 15–22.
More… ↓
⤷ Start Trial
|
